Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?

Grijalva CG, Moore MR, Griffin MR.

Lancet Infect Dis. 2011 Oct;11(10):724-6. doi: 10.1016/S1473-3099(11)70143-8. Epub 2011 May 27. No abstract available.

PMID:
21621465
2.

Streptococcus vaccination and MRSA.

Russell CD.

Lancet Infect Dis. 2012 Aug;12(8):586. doi: 10.1016/S1473-3099(12)70167-6. No abstract available.

PMID:
22835894
3.

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Lancet Infect Dis. 2011 Oct;11(10):760-8. doi: 10.1016/S1473-3099(11)70090-1. Epub 2011 May 27.

PMID:
21621466
4.

[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].

Traut V.

Dtsch Med Wochenschr. 2008 May;133(22):1207-8; author reply 1208. doi: 10.1055/s-2008-1077241. German. No abstract available.

PMID:
18491279
5.

Pneumococcal vaccines in adults: assessing the evolving evidence.

Grabenstein JD, Manoff SB.

Vaccine. 2011 Aug 26;29(37):6149-54. doi: 10.1016/j.vaccine.2011.06.116. Epub 2011 Jul 16. No abstract available.

PMID:
21763386
6.

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ.

BMC Infect Dis. 2010 Apr 8;10:90. doi: 10.1186/1471-2334-10-90.

7.

Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.

Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker-Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW.

Pediatr Infect Dis J. 2008 Apr;27(4):335-40. doi: 10.1097/INF.0b013e318161434d.

PMID:
18316986
8.

[Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].

Aguilar L, Giménez MJ.

Rev Esp Quimioter. 2007 Mar;20(1):125-7. Review. Spanish. No abstract available.

9.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
10.

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.

Giglio N, Micone P, Gentile A.

Vaccine. 2011 Sep 14;29 Suppl 3:C35-42. doi: 10.1016/j.vaccine.2011.06.095. Review.

PMID:
21896351
11.

Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine.

Durando P, Alicino C, De Florentiis D, Martini M, Icardi G.

J Prev Med Hyg. 2012 Jun;53(2):68-77. Review.

PMID:
23240163
12.

Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.

Azzari C, Resti M.

Clin Infect Dis. 2008 Oct 15;47(8):997-9. doi: 10.1086/591967. No abstract available.

PMID:
18781870
13.

Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?

Musher DM.

Clin Infect Dis. 2012 Jul;55(2):265-7. doi: 10.1093/cid/cis364. Epub 2012 Apr 11. No abstract available.

PMID:
22495544
14.

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.

Pediatr Infect Dis J. 2009 Nov;28(11):990-5. doi: 10.1097/INF.0b013e3181a78185.

PMID:
19536041
15.

The fundamental link between pneumococcal carriage and disease.

Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group.

Expert Rev Vaccines. 2012 Jul;11(7):841-55. Review.

PMID:
22913260
16.

Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].

Rodgers GL, Arguedas A, Cohen R, Dagan R.

Vaccine. 2009 Sep 4;27(40):5429-30. doi: 10.1016/j.vaccine.2009.07.020. Epub 2009 Jul 28. No abstract available.

PMID:
19643215
17.

Immunogenic protein contaminants in pneumococcal vaccines.

Yu J, Briles DE, Englund JA, Hollingshead SK, Glezen WP, Nahm MH.

J Infect Dis. 2003 Mar 15;187(6):1019-23. Epub 2003 Mar 6.

PMID:
12660950
18.

Reference laboratory agreement on multianalyte pneumococcal antibody results: an absolute must!

Hill HR, Pickering JW.

Clin Vaccine Immunol. 2013 Jul;20(7):955-6. doi: 10.1128/CVI.00325-13. Epub 2013 May 22. No abstract available.

19.

Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Balmer P, Cant AJ, Borrow R.

J Clin Pathol. 2007 Apr;60(4):345-50. Epub 2006 Sep 1. Review.

20.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859

Supplemental Content

Support Center